ESMO2016

Eye on ESMO: Day Three - Merck & Co. wins big lung cancer ba...
Day three at the European Society for Medical Oncology 2016 congress belonged to Merck & Co., and may well be seen as a hugely significant day in the future of lung cancer treatment.